- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in the curative management of oesophageal cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-21
DOI
10.1038/s41416-021-01485-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Feasibility of Patient-Specific Circulating Tumor DNA Monitoring throughout Multi-Modality Therapy for Locally Advanced Esophageal and Rectal Cancer: A Potential Biomarker for Early Detection of Subclinical Disease
- (2021) Christopher Boniface et al. Diagnostics
- Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity
- (2021) N.E. Donlon et al. CANCER LETTERS
- Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
- (2021) Ronan J. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- 548 COMPARISON OF ESOPHAGECTOMY OUTCOMES BETWEEN A NATIONAL CENTER, A NATIONAL AUDIT COLLABORATIVE, AND AN INTERNATIONAL DATABASE USING ECCG STANDARDIZED DEFINITIONS
- (2021) John V Reynolds et al. DISEASES OF THE ESOPHAGUS
- Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study
- (2020) Xiaobin Zhang et al. BMC CANCER
- Endoscopic Submucosal Dissection/Endoscopic Mucosal Resection Guidelines for Esophageal Cancer
- (2020) Ryu Ishihara et al. Digestive Endoscopy
- A randomized controlled phase III multicenter study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer: ARTDECO study.
- (2020) Maarten C.C.M. Hulshof et al. JOURNAL OF CLINICAL ONCOLOGY
- Definitive Chemoradiotherapy Compared to Neoadjuvant Chemoradiotherapy With Esophagectomy for Locoregional Esophageal Cancer
- (2020) Sivesh K. Kamarajah et al. ANNALS OF SURGERY
- Global Burden of 5 Major Types Of Gastrointestinal Cancer
- (2020) Melina Arnold et al. GASTROENTEROLOGY
- Implementation of Minimally Invasive Esophagectomy From a Randomized Controlled Trial Setting to National Practice
- (2020) Sheraz R. Markar et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO.
- (2020) Ralf Dieter Hofheinz et al. JOURNAL OF CLINICAL ONCOLOGY
- First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial
- (2020) Yelena Y Janjigian et al. LANCET ONCOLOGY
- Endoscopic eradication therapy for Barrett's oesophagus: state of the art
- (2020) Jennifer M. Kolb et al. CURRENT OPINION IN GASTROENTEROLOGY
- Diagnostic performance of magnifying blue laser imaging versus magnifying narrow-band imaging for identifying the depth of invasion of superficial esophageal squamous cell carcinoma
- (2020) Tomohiro Ueda et al. DISEASES OF THE ESOPHAGUS
- LBA6_PR Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study
- (2020) M. Moehler et al. ANNALS OF ONCOLOGY
- RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV
- (2020) Sylvie Lorenzen et al. BMC CANCER
- Delivering esophago-gastric cancer care during the COVID-19 pandemic in the United Kingdom: a surgical perspective
- (2020) S Wahed et al. DISEASES OF THE ESOPHAGUS
- 257 CHEMORADIOTHERAPY FOLLOWED BY ACTIVE SURVEILLANCE VERSUS SURGERY FOR ESOPHAGEAL CANCER: A SYSTEMATIC REVIEW AND INDIVIDUAL PATIENT DATA META-ANALYSIS
- (2020) B Van Der Wilk et al. DISEASES OF THE ESOPHAGUS
- Frequent tumor burden monitoring of esophageal squamous cell carcinoma with circulating tumor DNA using individually designed digital PCR
- (2020) Takeshi Iwaya et al. GASTROENTEROLOGY
- Minimally Invasive Esophagectomy: Time to Reflect on Contemporary Outcomes
- (2020) Bas P.L. Wijnhoven et al. JOURNAL OF CLINICAL ONCOLOGY
- Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials
- (2020) Torben Glatz et al. Journal of Clinical Medicine
- Targeted therapy for upper gastrointestinal tract cancer: current and future prospects
- (2020) Matthew W Rosenbaum et al. HISTOPATHOLOGY
- Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer
- (2020) Smita Sihag et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Progress in Multimodal Treatment for Advanced Esophageal Squamous Cell Carcinoma: Results of Multi-Institutional Trials Conducted in Japan
- (2020) Kazuo Koyanagi et al. Cancers
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer
- (2019) Christophe Mariette et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of Neoadjuvant Radiation Dose on Patients Undergoing Esophagectomy and Survival in Locally Advanced Esophageal Cancer
- (2019) Mickey S. Ising et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Long-term Survival in Esophageal Cancer After Minimally Invasive Compared to Open Esophagectomy
- (2019) Eivind Gottlieb-Vedi et al. ANNALS OF SURGERY
- The emerging role of immunotherapy for esophageal cancer
- (2019) Ronan J. Kelly CURRENT OPINION IN GASTROENTEROLOGY
- Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma
- (2019) Keiko Minashi et al. GASTROENTEROLOGY
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Quality Assurance of Dose Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal Cancer
- (2019) Jihane Boustani et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The Molecular Biologic Basis of Esophageal and Gastric Cancers
- (2019) Arjun Pennathur et al. SURGICAL CLINICS OF NORTH AMERICA
- Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
- (2019) Melina Arnold et al. LANCET ONCOLOGY
- Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
- (2019) Ken Kato et al. LANCET ONCOLOGY
- Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers
- (2019) Arnulf H. Hölscher et al. Gastric Cancer
- Clinical Practice Update: Endoscopic treatment of Barrett’s esophagus with dysplasia and/or early cancer
- (2019) Prateek Sharma et al. GASTROENTEROLOGY
- Endoscopic management of esophageal cancer
- (2019) Osman Ahmed et al. World Journal of Gastrointestinal Oncology
- Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial
- (2018) Bo Jan Noordman et al. BMC CANCER
- Patients' preferences for treatment after neoadjuvant chemoradiotherapy for oesophageal cancer
- (2018) B. J. Noordman et al. BRITISH JOURNAL OF SURGERY
- Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett’s esophagus
- (2018) Ryu Ishihara et al. JOURNAL OF GASTROENTEROLOGY
- Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
- (2018) Bo Jan Noordman et al. LANCET ONCOLOGY
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- A single-arm confirmatory study of definitive chemoradiotherapy (dCRT) including salvage treatment in patients (pts) with clinical (c) stage II/III esophageal carcinoma (EC) (JCOG0909).
- (2018) Yoshinori Ito et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
- (2018) Hong Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2
- (2018) Yuko Kitagawa et al. Esophagus
- Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1
- (2018) Yuko Kitagawa et al. Esophagus
- Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer
- (2018) Pieter C. van der Sluis et al. ANNALS OF SURGERY
- Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience
- (2018) David Graham et al. WORLD JOURNAL OF GASTROENTEROLOGY
- NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
- (2017) Somnath Mukherjee et al. EUROPEAN JOURNAL OF CANCER
- Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.
- (2017) Karyn A. Goodman et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial
- (2017) David Cunningham et al. LANCET ONCOLOGY
- Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
- (2017) Derek Alderson et al. LANCET ONCOLOGY
- Outcomes for Esophageal Squamous Cell Carcinoma Treated with Curative Intent in a Western Cohort: Should Multimodal Therapy Be the Gold Standard?
- (2017) Fiachra Sheil et al. WORLD JOURNAL OF SURGERY
- A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
- (2016) F. Klevebro et al. ANNALS OF ONCOLOGY
- Can CT-PET and Endoscopic Assessment Post-Neoadjuvant Chemoradiotherapy Predict Residual Disease in Esophageal Cancer?
- (2016) Helen M. Heneghan et al. ANNALS OF SURGERY
- Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial
- (2016) Mathieu Messager et al. BMC CANCER
- ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)
- (2016) Jens Hoeppner et al. BMC CANCER
- Clinical impact of tumour biology in the management of gastroesophageal cancer
- (2016) Florian Lordick et al. Nature Reviews Clinical Oncology
- Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society
- (2016) Tsuneo Oyama et al. Esophagus
- TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)
- (2015) Trevor Leong et al. BMC CANCER
- Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
- (2015) Joel Shapiro et al. LANCET ONCOLOGY
- Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer
- (2014) J M Blazeby et al. BRITISH JOURNAL OF CANCER
- Radiobiological Determination of Dose Escalation and Normal Tissue Toxicity in Definitive Chemoradiation Therapy for Esophageal Cancer
- (2014) Samantha Warren et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma
- (2013) Hiroki Hara et al. CANCER SCIENCE
- Oesophageal Chemoradiotherapy in the UK—Current Practice and Future Directions
- (2013) S. Gwynne et al. CLINICAL ONCOLOGY
- Long-term Efficacy and Safety of Endoscopic Resection for Patients With Mucosal Adenocarcinoma of the Esophagus
- (2013) Oliver Pech et al. GASTROENTEROLOGY
- Three-arm Phase III Trial Comparing Cisplatin Plus 5-FU (CF) Versus Docetaxel, Cisplatin Plus 5-FU (DCF) Versus Radiotherapy with CF (CF-RT) as Preoperative Therapy for Locally Advanced Esophageal Cancer (JCOG1109, NExT Study)
- (2013) Kenichi Nakamura et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Gene expression profiles in esophageal adenocarcinoma predict survival after resection
- (2013) Arjun Pennathur et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies
- (2013) Edward J. Bergeron et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort
- (2012) N. K. S. Cheedella et al. ANNALS OF ONCOLOGY
- Outcomes After Minimally Invasive Esophagectomy
- (2012) James D. Luketich et al. ANNALS OF SURGERY
- Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial
- (2012) Surya SAY Biere et al. LANCET
- Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
- (2012) P. van Hagen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
- (2011) Marc Ychou et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-FDG PET-Guided Salvage Neoadjuvant Radiochemotherapy of Adenocarcinoma of the Esophagogastric Junction: The MUNICON II Trial
- (2011) C. Meyer zum Buschenfelde et al. JOURNAL OF NUCLEAR MEDICINE
- Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial
- (2010) Bryan H. Burmeister et al. EUROPEAN JOURNAL OF CANCER
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
- (2009) Michael Stahl et al. JOURNAL OF CLINICAL ONCOLOGY
- Indications and outcome of salvage surgery for oesophageal cancer☆
- (2008) Xavier-Benoit D’Journo et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now